Suppr超能文献

人雌激素硫酸转移酶:半反应位点酶。

The human estrogen sulfotransferase: a half-site reactive enzyme.

机构信息

Microbiology and Immunology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, New York 10461-1926, USA.

出版信息

Biochemistry. 2010 Jun 15;49(23):4779-85. doi: 10.1021/bi902190r.

Abstract

The affinity of 17beta-estradiol (E(2)) for the estrogen receptor is weakened beyond the point of physiological relevance by the transfer of the sulfuryl moiety (-SO(3)) from PAPS (3'-phosphoadenosine 5'-phosphosulfate) to the 3'-hydroxyl of E(2). The mechanism of this transfer reaction, catalyzed by estrogen sulfotransferase (EST), is investigated here in detail. The enzyme (a dimer of identical protomers) presents a clear example of half-sites reactivity--only one of the subunits of the dimer produces product during the catalytic cycle. This is the first example of half-sites reactivity in the sulfotransferase family. A burst of product, with an amplitude that corresponds to one-half of the available active sites, reveals that the mechanism is rate-limited by product release. The equilibrium constant governing interconversion of the substrate (E.PAPS.E(2)) and product (E.PAP.E(2)S) central complexes was determined and is strongly biased toward product (K(eq int) approximately 49). Slow product release allows the interconversion of the central complexes to approach equilibrium, with the result that K(eq int) becomes nearly linearly coupled to K(m) and contributes a factor of approximately 30 to the steady-state affinity of the enzyme for substrate. Typical of its family, estrogen sulfotransferase is partially k(cat)-inhibited by its acceptor substrate, E(2). This inhibition does not influence the burst kinetics and thus occurs after formation of the product central complex, a finding consistent with the slow escape of PAP from the nonreactive E.PAP.E(2) complex.

摘要

17β-雌二醇(E(2))与雌激素受体的亲和力通过将 PAPS(3'-磷酸腺苷 5'-磷酸硫酸酯)的磺酰基(-SO(3))转移到 E(2)的 3'-羟基而减弱到生理相关范围之外。 在这里详细研究了由雌激素磺基转移酶(EST)催化的这种转移反应的机制。 该酶(两个相同亚基的二聚体)提供了半位反应性的明显例子-只有二聚体的一个亚基在催化循环中产生产物。 这是磺基转移酶家族中半位反应性的第一个例子。 产物爆发,幅度对应于可用活性部位的一半,表明该机制受到产物释放的限制。 控制底物(E.PAPS.E(2))和产物(E.PAP.E(2)S)中心复合物之间相互转化的平衡常数被确定,并且强烈偏向于产物(K(eq int)约为 49)。 产物的缓慢释放允许中心复合物之间的相互转化接近平衡,结果使 K(eq int)与 K(m)几乎线性耦合,并使酶对底物的稳态亲和力增加约 30 倍。 磺基转移酶与其家族典型的部分 k(cat)-受其受体底物 E(2)抑制。 这种抑制不影响爆发动力学,因此发生在产物中心复合物形成之后,这一发现与 PAP 从非反应性 E.PAP.E(2)复合物中缓慢逸出一致。

相似文献

1
The human estrogen sulfotransferase: a half-site reactive enzyme.
Biochemistry. 2010 Jun 15;49(23):4779-85. doi: 10.1021/bi902190r.
2
Sulfuryl transfer: the catalytic mechanism of human estrogen sulfotransferase.
J Biol Chem. 1998 May 1;273(18):10888-92. doi: 10.1074/jbc.273.18.10888.
4
Correlation between PAP-dependent steroid binding activity and substrate specificity of mouse and human estrogen sulfotransferases.
J Steroid Biochem Mol Biol. 1999 Dec 15;71(3-4):123-31. doi: 10.1016/s0960-0760(99)00131-4.
5
Kinetic measurements and mechanism determination of Stf0 sulfotransferase using mass spectrometry.
Anal Biochem. 2005 Jun 1;341(1):94-104. doi: 10.1016/j.ab.2005.02.004.
6
Synthesis of a bisubstrate analogue targeting estrogen sulfotransferase.
J Org Chem. 2003 Jan 10;68(1):170-3. doi: 10.1021/jo0260443.
9
Isotope exchange at equilibrium indicates a steady state ordered kinetic mechanism for human sulfotransferase.
Biochemistry. 2008 Nov 11;47(45):11894-9. doi: 10.1021/bi801211t. Epub 2008 Oct 18.

引用本文的文献

1
The N-Terminus of Human Sulfotransferase 2B1b─a Sterol-Sensing Allosteric Site.
Biochemistry. 2022 May 17;61(10):843-855. doi: 10.1021/acs.biochem.1c00740. Epub 2022 May 6.
2
From Steroid and Drug Metabolism to Glycobiology, Using Sulfotransferase Structures to Understand and Tailor Function.
Drug Metab Dispos. 2022 Jul;50(7):1027-1041. doi: 10.1124/dmd.121.000478. Epub 2022 Feb 22.
3
The molecular basis of OH-PCB estrogen receptor activation.
J Biol Chem. 2021 Jan-Jun;296:100353. doi: 10.1016/j.jbc.2021.100353. Epub 2021 Jan 30.
4
Small-molecule control of neurotransmitter sulfonation.
J Biol Chem. 2021 Jan-Jun;296:100094. doi: 10.1074/jbc.RA120.015177. Epub 2020 Nov 24.
5
Allosteres to regulate neurotransmitter sulfonation.
J Biol Chem. 2019 Feb 15;294(7):2293-2301. doi: 10.1074/jbc.RA118.006511. Epub 2018 Dec 13.
6
Isoform-specific therapeutic control of sulfonation in humans.
Biochem Pharmacol. 2019 Jan;159:25-31. doi: 10.1016/j.bcp.2018.11.010. Epub 2018 Nov 10.
7
The NSAID allosteric site of human cytosolic sulfotransferases.
J Biol Chem. 2017 Dec 8;292(49):20305-20312. doi: 10.1074/jbc.M117.817387. Epub 2017 Oct 16.
8
Expression, purification and characterization of human cytosolic sulfotransferase (SULT) 1C4.
Horm Mol Biol Clin Investig. 2017 Jan 1;29(1):27-36. doi: 10.1515/hmbci-2016-0053.
9
The structure of the catechin-binding site of human sulfotransferase 1A1.
Proc Natl Acad Sci U S A. 2016 Dec 13;113(50):14312-14317. doi: 10.1073/pnas.1613913113. Epub 2016 Nov 23.
10
Isozyme Specific Allosteric Regulation of Human Sulfotransferase 1A1.
Biochemistry. 2016 Jul 26;55(29):4036-46. doi: 10.1021/acs.biochem.6b00401. Epub 2016 Jul 13.

本文引用的文献

1
RETRACTED: A type I-secreted, sulfated peptide triggers XA21-mediated innate immunity.
Science. 2009 Nov 6;326(5954):850-3. doi: 10.1126/science.1173438.
3
Dimerization is responsible for the structural stability of human sulfotransferase 1A1.
Drug Metab Dispos. 2009 May;37(5):1083-8. doi: 10.1124/dmd.108.025395. Epub 2009 Feb 23.
5
Chemistry and biology of heparin mimetics that bind to fibroblast growth factors.
Mini Rev Med Chem. 2007 Dec;7(12):1206-35. doi: 10.2174/138955707782795665.
7
Human sulfatases: a structural perspective to catalysis.
Cell Mol Life Sci. 2007 Aug;64(15):2013-22. doi: 10.1007/s00018-007-7175-y.
8
Channeling in sulfate activating complexes.
Biochemistry. 2006 Sep 26;45(38):11304-11. doi: 10.1021/bi060421e.
9
Estrogen sulfatase.
Methods Enzymol. 2005;400:293-302. doi: 10.1016/S0076-6879(05)00017-0.
10
Coupling phosphoryl transfer and substrate interactions in protein kinases.
Biochim Biophys Acta. 2005 Dec 30;1754(1-2):191-9. doi: 10.1016/j.bbapap.2005.07.024. Epub 2005 Sep 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验